Released on 2023-08-01

BI ImSAVAR PBMC RNA-seq Data

Accession number

ELU-2-3D4F13-1

Request Data Access

Export Metadata as DATS

Project

Project Title: Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
Project website: https://www.imi.europa.eu/projects-results/project-factsheets/imsavar

Studies

Study title: BI Immuno-stimulant study

General Dataset Information

Version: V1.0
Created on: -
Updated on: -
Experiment types: RNASeq
Type of Samples Collected: Blood
Number of Samples Collected: 0
Diseases in samples: Cytokine release symptome

Use restrictions

Permissions

Use Restriction	Remarks	Category (GA4GH)
Use is not limited to a specific research/disease area.	Limited scope of research. Is data consented to be used only in specific research/disease areas? E.g. use only in Biomedical Research.	Other Research-specific restrictions (RS)
Consent does not contain clauses of geographical restrictions.	Geographical restriction. Does consent contain clauses that put geographical restrictions to the sharing of data? E.g. not to be shared outside Country A, B, or EU/EEA.	Geographical Restrictions (GS)
Consent does not limit the type of recipients.	Restricted type of recipients. Does the consent limit the type of recipients? E.g. data can be sent only to a specific type of institution such as private research institutions or public research institutions or to a named list of institutions.	Institution-Specific restrictions (IS)
Consent does not put time-limits on data use.	Retention time. Does the consent contain clauses that put time-limits on the use of data?	Time Limits on use (TS)
There is no requirement to return data.	Data return requirements Is there a requirement to return data or documents to the database/resource?	Return data to database/resource (RTN)

Obligations

Use Restriction	Remarks	Category (GA4GH)
2024-12-31 or until completion of the imSAVAR project (whichever is earlier)	Time limit of storage at LCSB. Is the data being sent to ELIXIR-LU/LCSB for a limited duration?	Time Limits on use (TS)
Yes, those wishing to publish should contact Boehringer Ingelheim to ensure appropriate authorship contributions	Publication requirements Are there any requirements in case of publications based on the DATA? E.g. papers should cite the cohort study.	Publication Required (PUB)

Constrained permissions

Use Restriction	Remarks	Category (GA4GH)
Data access is limited to members of the imSAVAR consortium.	User specific restrictions Is the use limited to approved users/groups/institutions?	User-Specific restrictions (US)
Data can only be used persuant to the Access Rights as stipulated in the ImSAVAR Collaboration agreement.	Other restrictions	User-Specific restrictions (US)
Use must comply with the Access Rights as provided under the ImSAVAR Collaboration agreement.	Are there any Intellectual Property (IP) restrictions/requirements when using the DATA?	User-Specific restrictions (US)

Prohibitions

Use Restriction	Remarks	Category (GA4GH)
		Collaboration Required (COL)